AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
Sanjeev is currently the Country President for AstraZeneca Malaysia
Sanjeev is currently the Country President for AstraZeneca Malaysia
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
The current ruling will assure the safety of the use of Ranitidine for Indian patients
EC grants conditional marketing authorization based on the EFFISAYIL trial
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Subscribe To Our Newsletter & Stay Updated